









Markets
/
Stocks
/
nasdaq-gnta
/

Genenta Science SPA

GNTA

0.732USD

-0.006-0.79%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

14.02MMarket Cap

LossP/E TTM



Genenta Science SPA

0.732

-0.006-0.79%

Overview Financials Analysis Company

Overview

Financials

Analysis

Company

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Genenta Science SPA to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2024H2

FY2024H1

FY2023H2

FY2023H1

FY2022H2

FY2022H1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-15.01%-3.86M

73.41%-1.90M

23.95%-3.36M

-177.84%-7.16M

---4.42M

---2.58M

Net income from continuing operations

0.56%-4.50M

41.49%-3.73M

21.86%-4.53M

-200.99%-6.38M

---5.79M

---2.12M

Operating gains losses

4.74%20.68K

2.50%20.46K

552.03%19.74K

606.99%19.96K

--3.03K

--2.82K

Other non-cash items

-10.59%29.00K

-23.67%29.32K

-45.83%32.43K

55.73%38.41K

--59.87K

--24.66K

Change in working capital

-97.32%21.90K

227.76%1.57M

-6.78%815.87K

-69.29%-1.23M

--875.22K

---723.91K

-Change in prepaid expenses

15.23%-138.48K

311.87%755.46K

-122.14%-163.37K

70.83%-356.58K

--737.78K

---1.22M

-Change in other current assets

-93.02%71.05K

221.45%575.79K

228.46%1.02M

-206.61%-474.11K

---792.77K

--444.71K

-Change in other current liabilities

-253.27%-110.83K

269.63%183.49K

-13.17%72.31K

-141.48%-108.17K

--83.28K

--260.75K

Cash from non-recurring investing activities

Cash from operating activities

-15.01%-3.86M

73.41%-1.90M

23.95%-3.36M

-177.84%-7.16M

---4.42M

---2.58M

Investing cash flow

Net cash from continuing investing activities

91.35%2.40K

-85.28%1.73K

-94.32%1.25K

315.87%11.74K

--22.08K

--2.82K

Capital expenditures

91.35%2.40K

-85.28%1.73K

-94.32%1.25K

315.87%11.74K

--22.08K

--2.82K

Net cash flow from disposal of fixed assets

91.35%2.40K

-85.28%1.73K

-94.32%1.25K

315.87%11.74K

--22.08K

--2.82K

Net cash flow from investment products

152.71%2.39M

142.17%3.98M

---4.53M

---9.43M

----

Cash from non-current investing activities

Net cash flow from investing activities

152.65%2.39M

142.10%3.97M

-20426.51%-4.53M

-334332.69%-9.44M

---22.08K

---2.82K

Financing cash flow

Cash flow from continuous financing activities

-100.00%0.00

--250.40K

--491.99

--0.00

Net cash flow from common stock issuance/repurchase

----

--0.00

Proceeds from stock option exercised by employees

----

--0.00

Net cash flow from other financing activities

-100.00%0.00

--250.40K

--491.99

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

-100.00%0.00

--250.40K

--491.99

--0.00

Net cash flow

Beginning cash balance

-49.49%5.72M

-87.87%3.41M

-64.14%11.32M

-24.74%28.13M

--31.56M

--37.37M

Current period cash flow changes

81.21%-1.48M

113.90%2.31M

-77.90%-7.90M

-543.74%-16.60M

---4.44M

---2.58M

Effect of exchange rate changes

-16.95%-6.80K

---14.87K

---5.82K

----

Ending cash balance

23.73%4.23M

-50.39%5.72M

-87.39%3.42M

-66.87%11.53M

--27.12M

--34.80M

Free cash flow

-15.04%-3.86M

73.43%-1.90M

24.30%-3.36M

-178.00%-7.17M

---4.44M

---2.58M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

